NCT02167035View on ClinicalTrials.gov

Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)

PHASE4CompletedINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

Combigan Two Times Daily (BID)

DRUG

Simbrinza Three Times Daily (TID)

Trial Locations (1)

27262

Cornerstone Health Care, High Point

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

Cornerstone Health Care, PA

OTHER